SANWAY GENE
LIVE

Serial Number

79398160

Owner

Sanway Gene Tech. Inc.

Attorney

Yue (Robert) Xu

Filing Date

Jan 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SANWAY GENE Trademark

Serial Number: 79398160 • Registration: 7656782

SANWAY GENE is a trademark filed by Sanway Gene Tech. Inc. on January 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Sanway Gene Tech. Inc.

5F, Testing Building of Sansure Biotech Inc.,

Entity Type: 99

Trademark Details

Filing Date

January 5, 2024

Registration Date

January 21, 2025

Published for Opposition

December 3, 2024

Goods & Services

Surgical apparatus and instruments; apparatus for use in medical analysis, namely, apparatus for blood analysis, body composition analyzers, apparatus for analyzing and detecting bacteria and viruses, apparatus for analyzing and detecting DNA and RNA, apparatus for analyzing and detecting genes, apparatus for analyzing blood vessels, apparatus for immunoassay analysis, apparatus for organ and tissue cavitation detecting, and apparatus for medical imaging analysis; diagnostic apparatus for medical purposes in the nature of medical diagnostic imaging apparatus, for use with computer displays and computer monitors and for use with recorded computer operating software and recorded smartphone operating software, all sold as a unit; body composition analyzers for medical purposes; apparatus for DNA and RNA testing for medical purposes; analysers for bacterial identification for medical purposes; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; genetic testing apparatus for medical purposes; medical equipment, namely, devices for bioanalysis of pathogens in the nature of reagent cartridges for sample preparation, nucleic acid purification, nucleic acid amplification and electrochemical detection all for medical diagnostic purposes; gene testing medical apparatus for identification of genus specific and species specific DNA and RNA sequences; immunochemical testing apparatus for medical use; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for testing DNA and RNA samples

Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; antibiotics; vaccine preparations; pharmaceutical preparations for treating allergies; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medical use; genetic identity tests comprised of reagents for medical purposes; reagent paper for medical purposes; reagents for medical use; biological preparations for medical purposes for the prevention and treatment of disorders of the digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and of the genitourinary system, for the prevention and treatment of infectious diseases, viral diseases, and inflammatory disorders, for use in dermatology, oncology, hematology, tissue and organ transplantation, and ophthalmology and for the treatment of gastroenterological disorders; diagnostic biomarker reagents for medical purposes; immunoassay reagents for medical use; enzyme preparations for medical purposes; reagents for use in medical genetic testing; mineral, vitamin, or nutritionally enhanced water for medical purposes; medicated water for the treatment of illnesses attributed to insufficient cellular energy; medicated water for the treatment of allergies, cough, cold, flu, headache, and pain; medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal tissue diseases and conditions; medicated water for the treatment of pain, nausea and muscle spasms; medicated water-based solutions for treating skin infections and skin conditions; medicated water for the treatment of gastrointestinal disorders; demineralised water for medical purposes; diagnostic kits comprised of medical diagnostic reagents for use in disease testing, health monitoring, and predictive and preventive medicine in the fields of detecting diseases related to cancer, infectious diseases, viral diseases, hereditary diseases, inflammatory disorders, and oncological disorders of the digestive system, blood system, reproductive system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; purified biochemical medical diagnostic reagents, namely, protein arrays, enzymes, and fluorescent dyes for use as reagents in medical diagnostic applications; biological preparations for the diagnosis of disorders of the digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the diagnosis of cancer, hereditary diseases, infectious diseases, viral diseases, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; biological preparations for the treatment of disorders of the digestive system, blood system, the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the treatment of cancer, hereditary diseases, infectious diseases, viral diseases, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; biochemical drugs for the diagnosis of disorders of the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the diagnosis of cancer, infectious diseases, viral diseases, hereditary diseases, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; biochemical drugs for the treatment of disorders of the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system and for the treatment of cancer, infectious diseases, viral diseases, hereditary diseases, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; antibiotic tablets; allergy tablets; chemico-pharmaceutical preparations in the nature of biological indicators, in-vivo diagnostic agents, and in-vitro diagnostic reagents all for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, hereditary diseases, viral diseases, and diseases related to the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, and in-vitro diagnostic reagents all for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, hereditary diseases, viral diseases, and diseases related to the digestive system, blood system, the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; antibiotic ointments; anti-inflammatory ointments; medicated ointments for treating dermatological conditions; ointments for pharmaceutical purposes, namely, anti-itch ointments, hemorrhoidal ointments

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 5, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 19, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 19, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 29, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 7, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 7, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 22, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 16, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 9, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 19, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 17, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 8, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 7, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 1, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 2, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 2, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 28, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 20, 2024 REPR